For the first time, researchers are reporting that a treatment might help stabilize Alzheimer’s disease for as much as three years, but the evidence is weak and only in four patients.   The treatment is Gammagard, made by Baxter International Inc. Doctors say that four patients who received the highest dose in early […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly If you're already a member, sign in here.